JAMAVerified account

@JAMA_current

JAMA is an international peer-reviewed general medical journal published weekly online and in print, and a member of the family of journals.

Chicago, IL
Joined May 2009

Tweets

You blocked @JAMA_current

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @JAMA_current

  1. 8 hours ago

    Study found mental stress–induced myocardial ischemia was significantly associated with an increased risk of cardiovascular events in patients with coronary heart disease

    Undo
  2. 14 hours ago

    In a randomized trial of patients with and severe hypoxemia, compared with 6 mg of dexamethasone, 12 mg of dexamethasone did not statistically significantly reduce the number of days alive without life support at 28 days

    Undo
  3. Nov 8

    Among Danish public schoolchildren, maternal antidepressant Rx during pregnancy was assoc'd w statistically significantly lower standardized test scores in mathematics, albeit small differences, and no significant difference in language test scores

    Undo
  4. Nov 5

    Among children with CAP discharged from an ED or hospital ward (within 48 hours), low-dose outpatient oral amoxicillin was noninferior to high dose, and 3-day duration was noninferior to 7 days, with regard to need for further antibiotic re-treatment

    Undo
  5. Nov 5

    Among children with CAP discharged from an ED or hospital ward (within 48 hours), low-dose outpatient oral amoxicillin was noninferior to high dose, and 3-day duration was noninferior to 7 days, with regard to need for further antibiotic re-treatment

    Undo
  6. Nov 5

    Among children with CAP discharged from an ED or hospital ward (within 48 hours), low-dose outpatient oral amoxicillin was noninferior to high dose, and 3-day duration was noninferior to 7 days, with regard to need for further antibiotic re-treatment

    Undo
  7. Nov 4

    Study found vaccination with an mRNA COVID-19 vaccine was significantly less likely among patients with hospitalization and with disease progression, consistent with risk reduction among vaccine breakthrough infections

    Undo
  8. Nov 3

    Data do not support the use of aspirin or apixaban in the outpatient setting to reduce the major adverse cardiovascular or pulmonary consequences associated with symptomatic but clinically stable infection

    Undo
  9. Nov 2

    Study found, among critically ill adults with confirmed , treatment with convalescent plasma had a low likelihood of providing improvement in organ support–free days

    Undo
  10. Nov 1

    Study found prior infection was associated with lower risk for breakthrough infection among persons receiving the SARS-CoV-2 mRNA vaccines; however, the observational study design precludes direct comparison of infection risk btwn the 2 vaccines

    Undo
  11. Oct 29

    Study found that, among patients with STEMI, a concomitant diagnosis of was associated with significantly higher rates of in-hospital mortality

    Undo
  12. Oct 28

    Study suggests a potential small but statistically significant safety concern for syndrome following receipt of the vaccine; findings considered preliminary pending analysis of medical records to establish a definitive Dx

    Undo
  13. Oct 27

    Study results do not support the use of platelet-rich plasma injections for ankle osteoarthritis

    Undo
  14. Oct 26

    Randomized trial among patients with in-hospital cardiac arrest found that administration of vasopressin and methylprednisolone, compared with placebo, significantly increased the likelihood of return of spontaneous circulation

    Undo
  15. Oct 22

    In outpatients, new prescription of tramadol, vs codeine, was significantly associated with a higher risk of mortality, CV events, and fractures, but not other outcomes; the findings should be interpreted cautiously due to possible residual counfounding

    Undo
  16. Oct 21

    In a randomized trial of patients with and severe hypoxemia, compared with 6 mg of dexamethasone, 12 mg of dexamethasone did not statistically significantly reduce the number of days alive without life support at 28 days

    Undo
  17. Oct 21

    In a randomized trial of patients with and severe hypoxemia, compared with 6 mg of dexamethasone, 12 mg of dexamethasone did not statistically significantly reduce the number of days alive without life support at 28 days

    Undo
  18. Oct 21

    In a randomized trial of patients with and severe hypoxemia, compared with 6 mg of dexamethasone, 12 mg of dexamethasone did not statistically significantly reduce the number of days alive without life support at 28 days

    Undo
  19. Oct 20

    In this RCT, in comatose survivors of out-of-hospital cardiac arrest, a target therapeutic hypothermia temperature of 31 °C did not significantly reduce the rate of death or poor neurologic outcome at 180 days compared with a target temperature of 34 °C

    Undo
  20. Oct 20

    In this RCT, in comatose survivors of out-of-hospital cardiac arrest, a target therapeutic hypothermia temperature of 31 °C did not significantly reduce the rate of death or poor neurologic outcome at 180 days compared with a target temperature of 34 °C

    Undo

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·